{"id":"W2113611444","doi":"10.1016/j.ijrobp.2012.07.033","title":"Phase I Study of Sorafenib and SBRT for Advanced Hepatocellular Carcinoma","year":2012,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Sorafenib; Medicine; Hepatocellular carcinoma; Toxicity; Liver function; Nuclear medicine; Phases of clinical research; Liver cancer; Internal medicine; Gastroenterology; Urology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001626075,0.00148542,0.003315611,0.0006521533,0.0005304152,0.001129842,0.0009248705,0.0009622213,0.0036998],"category_scores_gemma":[0.0007824837,0.000808367,0.001857444,0.0005905317,0.001395799,0.0009301229,0.0004351734,0.002787781,0.00100804],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001240789,"about_ca_system_score_gemma":0.002290691,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00236951,"about_ca_topic_score_gemma":0.004253829,"domain_scores_codex":[0.9995515,0.0002113043,0.00001920744,0.00007110873,0.00003764072,0.0001092916],"domain_scores_gemma":[0.9992998,0.0000988529,0.00009452457,0.00008125062,0.00004652323,0.0003791277],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7975972,0.08040946,0.003945584,0.001056965,0.002563973,0.0001804351,0.0004463083,0.00658959,0.03033302,0.0005785901,0.002952576,0.07334635],"study_design_scores_gemma":[0.4447902,0.5404199,0.005117565,0.00002994269,0.0007179374,0.000202056,0.0001490477,0.001834131,0.003901791,0.0003337076,0.002468043,0.00003568405],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947884,0.001692473,0.0004710603,0.000335718,0.000155042,0.00110144,0.0004926135,0.00006335862,0.0008999123],"genre_scores_gemma":[0.9909956,0.002193929,0.001177504,0.0003455574,0.000121691,0.001443765,0.001177926,0.00003458951,0.002509617],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0036998,"threshold_uncertainty_score":0.01237708,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0605609459128553,"score_gpt":0.3510709085624358,"score_spread":0.2905099626495805,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}